Clinical Trial Update: Werewolf Flow 50 During ACL Reconstruction [NA]

View source ↗

Summary

Clinical trial update on Werewolf Flow 50 used during ACL reconstruction; the study sponsored by University of Colorado, Denver is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury
• Arthrofibrosis of the Knee

Drugs mentioned

• Werewolf Flow 50

Snippet

Sponsor: University of Colorado, Denver | Conditions: Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture | NA | Status: COMPLETED